Belgium Patient Support Programs (PSP) Market Analysis Sample Report

Belgium Patient
Support Programs
(PSP) Market
Analysis
A sample report on
Includes Market Size, Market Segmented by
Types and Key Competitors (Data forecasts
from 2023 – 2030F)
www.insights10.com

This report presents a strategic analysis of the Belgium Patient
Support Programs (PSP) Market and a forecast for its development in
the medium and long term. It provides a comprehensive overview of the
market value, dynamics, segmentation, main players, growth and demand
drivers, challenges & future outlook, etc. This is one of the most
comprehensive reports about the Belgium Patient Support Programs
(PSP) Market, and offers unmatched value, accuracy, and expert insights.

3
A Sample Report on Belgium Patient Support Programs (PSP) Market Analysis I Confidential
Report Scope
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2022
Forecast Period 2023-2030
Report Coverage
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape,
Reimbursement Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Research Approach Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology

4
Table of Content
CONTENT PG. NO.
1. Patient Support Programs (PSP) Overview 06-19
1.1. Overview
1.2. Belgium Overview
1.3. Economic Overview: Belgium
1.4. Patient Support Programs (PSP) Market in Belgium
1.5. Healthcare Services Market in Belgium
1.6. Healthcare Scenario in Belgium
1.7. Health Insurance Coverage: Belgium
1.8. Budget of the Government for Public Insurance
1.9. Mergers and Acquisitions
2. Market Size and Forecasting 20-26
2.1 Market size and forecasts (Excel and Methodology)

5
Table of Content
CONTENT PG. NO.
2.2. Market Segmentation
3. Market Dynamics 27-31
3.1. Market Growth Drivers
3.2. Market Restraints
4. Competitive Landscape 32-42
4.1. Major Market Share
4.2. Key Company Profile
5. Reimbursement Scenario 43-48
5.1. Reimbursement Regulation
5.2. Reimbursement Process for Diagnosis
5.3. Reimbursement Process for Treatment
6. Methodology & Scope 49-54

Belgium Patient Support Programs (PSP) Market Analysis
1. Patient Support Programs (PSP) Overview

7
1.1 Statistics at a Glance: Patient Support Programs (PSP) in the World
Patient Support Programs (PSP) at
Global level ▪ Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪ In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
90%
Was PSPs impact
adherence after one
year
32%
Is the percentage increase in
number of PSP in the US
Unaffordability and Non-adherence
Are the major reasons for the impact of PSP market
$70.3 Bn
Is the forecasted
valuation of Global
PSP market for
year 2030
17.4%
Is the CAGR of the Global
PSP market for the period of
2023-2030

8
1.1 Statistics at a Glance: Patient Support Programs (PSP) in the World
(continued)
North America
~ Market Size of
XX Bn
Asia
-xx CAGR
Africa
~Market Size of XX
Bn
Belgium Market
XX Mn Market
Illustrative

9
1.2 Belgium Overview
11.65 Mn
Is the population of
Belgium, in 2022
42.3 years
Is the median age
in Belgium, in 2022
$554.6 Bn
Is the Gross
Domestic Product
(GDP) in Belgium in
2022
$5009.46
Per capita was the
amount of national
health expenditures in
2022
▪ Please be aware that this sample report is
report
understanding of the demographics of the
country/region, which includes the
population, GDP, healthcare expenditure
and other details related to the topic
interest

10
1.3 Economic Overview: Belgium
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
Population of Belgium, (2020-2030)
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
GDP of Belgium, (2020-2030)
Population Split (2023)
55-64
0-14
15-24
25-54
65+
Male
49%
Female
51%
By Age Group
By Gender
▪ In this section you will get an understanding of the demographics
of the country/region, which includes the population, GDP,
healthcare expenditure and other details related to the topic
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative

11
1.4 Patient Support Programs (PSP) in Belgium
▪ Please be aware that this sample report
is intended to provide you with a brief
analysis that will be presented in the
final report
understanding of the topic, which
includes the prevalence of the disease,
the application of medical devices, new
technology, and other details related to
the topic in Belgium
information that you are seeking, you
will need to purchase the final report
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
▪ Health Education and support ▪ Practical support
▪ Medication assistance ▪ Call Center Support
Main service providers in Patient support programs
Main services provided in Patient support programs
▪ Government Agencies
▪ Pharmaceutical Companies
▪ Non-profit Organizations
▪ Healthcare Providers and
Institutions
▪ Patient Advocacy Groups

12
1.5 Healthcare Services in Belgium
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Belgium Healthcare Services Market Forecast, 2022-2030 (in $Bn)
▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be
presented in the final report
▪ In this section you will get an understanding of the overall Healthcare Services market in Belgium, which includes the market size, current
trends and other details related to the topic
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or
Illustrative

13
1.6 Healthcare Scenario in Belgium
Belgium has a highly developed healthcare system that provides universal coverage for its residents. The healthcare system in Belgium is
funded through a combination of social security contributions and taxes, ensuring that everyone has access to healthcare services
▪ Universal Coverage: Belgian healthcare system provides universal coverage, which means that all legal residents have access to
necessary healthcare services. Non-residents may also receive emergency care
▪ Health Insurance: All residents are required to have health insurance, either through a government-run health insurance scheme or
private health insurance. The government insurance scheme is compulsory and covers a significant portion of the healthcare costs, while
private insurance can provide additional coverage and benefits
▪ Primary Care: Primary healthcare in Belgium is typically provided by general practitioners (GPs) who act as gatekeepers to specialized
care. Patients usually consult their GP first, who may then refer them to specialists or hospitals if needed
▪ Specialist Care and Hospitals: Belgium has a well-developed network of hospitals and specialized healthcare providers. Patients can
choose their healthcare providers and have the freedom to visit any hospital or specialist without a referral from a GP, although this may
affect reimbursement levels
▪ Reimbursement System: Belgian healthcare system operates on a reimbursement model. Patients pay for healthcare services upfront
and then submit reimbursement claims to their health insurance provider. Reimbursement rates depend on the type of service and the
insurance coverage
▪ Pharmaceuticals: Belgium has a comprehensive pharmaceutical system, and prescription medications are available through pharmacies.
The cost of prescription drugs is generally partially reimbursed, with patients paying a co-payment
Illustrative

14
1.6 Healthcare Scenario: Patient Journey
Presentation Diagnosis Treatment Follow up
A suspected diagnosis is
usually made, based on
physical examination and
detailed patient and family
history
Prenatal screening/
Neonatal screening
Initial Diagnosis
Complete blood count
(evaluate number &
quality of RBCs, Hb &
WBCs)
Imaging (confirm bone
related changes or
respiratory problems)
Bacterial cultures of
blood, sputum, urine,
stool (detect any
infection)
Genetic testing (detect
the type of SCD)
Confirmatory Diagnosis
Prevention and management of
crisis:
• For VOC and Splenic
Sequestration: HU, Endari,
Adakveo, Oxbryta
• For infections: Antibiotics,
Vaccines
Prevention and management of
complications:
• Stroke: Chronic transfusions, HU
• Long term follow-up is required for
patients with SCD
• Annual assessment: CBC and
reticulocyte count, iron status, liver
and renal function tests, urinalysis,
LDH, vitamin D level and
neurocognitive assessment
• ESOD (End Stage Organ Damage)
evaluation starting from age 7
• Yearly Transcranial Doppler test to
determine risk of stroke
Stakeholders
PCP, paediatrician,
neonatologist,
haematologist and genetic
counsellor
PCP, pediatrician, medical geneticist,
hematologist, gynecologist and pathologist
PCP, pediatrician, medical geneticist,
cardiologist, hematologist,
endocrinologist, psychologist and
psychiatrist
PCP, pediatrician, neonatologist,
endocrinologist, cardiologist,
hematologist, orthopedist, psychologist
and psychiatrist
Depending on the organ complications,
the treatment involves different
specialists at different times
Illustrative

15
1.7 Health Insurance Coverage: Belgium
1.0
35.7
2.5
3.5
10.2
54.3
66.0
91.7
8.3
VA and CHAMPVA
Any public plan
TRICARE
Marketplace
Direct-purchase
Employment-based
Any private plan
With health insurance
Uninsured
▪ In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire
calendar year
▪ Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%),
followed by Private (18.9%), Public (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%)
Coverage Type 2020 2021 Change %
Total 327,521 328,074
Any health plan 299,230 300,887 0.4
Any private plan 217,896 216,366 –0.6
Employment-based 178,737 178,285 –0.2
Direct-purchase 33,869 33,555 –0.1
Marketplace coverage 10,924 11,389 0.1
TRICARE 9,165 8,299 –0.3
Any public plan 112,925 117,095 1.2
VA and CHAMPVA 2,967 3,151 0.1
Uninsured 28,291 27,187 –0.4
% of People by Type of Health Insurance Coverage
(2021)
Number of People By Health Insurance Coverage
Illustrative

16
1.8 Budget of Belgium Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31
In Billions Of Dollars
Public
$769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
$458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926
As % Of GDP
3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4%
▪ National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪ Public spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE
▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE
▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE
▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE
▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020
▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020
▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020
▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health
spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative

17
1.9 Mergers and Acquisitions
$6.0
$7.7
$10.5
$16.7
$6.8
$11.7
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
82
112 107 107
89
110
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020
RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend
Buyer Composition: Strategic Vs Financial (2020)
59%
41% 41%
59% 58%
42%
61%
39%
$0- $25 $25-$50 $50-$100 $100+
Strategic Buyers
Financial Buyers
Buyer Type by Deal Size
($Mn)
Illustrative

18
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
ERT acquisition of
PatientConnect
Acquisition $191 Mn
October,
2022
▪ Acquisition of PatientConnect by ERT will allow ERT to expand its
patient support program capabilities in Belgium and across
Europe
▪ PatientConnect is a leading patient support services company in
Belgium, with a strong track record of providing high-quality
services to pharmaceutical companies
▪ Acquisition will give ERT access to PatientConnect's expertise
and resources, which will help ERT to grow its business in
Belgium and across Europe
Syneos Health
acquisition of Patient
Access Solutions
Acquisition $165 Mn July 2022
▪ Patient Access Solutions is a leading patient support services
company in Belgium, with a strong track record of providing high-
quality services to pharmaceutical companies
▪ Acquisition will give Syneos Health access to PatientAccess
Solutions' expertise and resources, which will help Syneos Health
to grow its business in Belgium and across Europe
▪ Acquisition of Patient Access Solutions by Syneos Health will
allow Syneos Health to expand its patient support program
capabilities in Belgium and across Europe
Latest Deals In Belgium

19
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Merger March 2023
Merger Jan 2023
Latest Deals In Belgium

2. Market Size and Forecasting

21
2.1 Market size and forecasts (Excel and Methodology)
XX
XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Belgium PSP Market Forecast, 2022-2030 (in $Bn)
final report
understanding of the overall Healthcare
Insurance market in Malaysia, which
includes the market size, current trends
and other details related to the topic
Click on the icon to know the
methodology and assumption
2023 2024 2025 2026 2027 2028 2029 2030
Major Markets Patient
(Mn)
2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Belgium Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of US Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937
Belgium Market Size (Bn
$)
61 74 84 87 91 95 99 106
Illustrative

22
2.2 Snapshot of PSP Market Segmentation
▪ In this section you will get an understanding of the segmentations which will cover the Belgium Patient Support Programs (PSP)
Market
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Functionality
Communication
Health Tracking &
Insights
Therapeutic Area
Health & Wellness
Chronic Disease
Management
Others
Application
Population Health
Management
Outpatient Health
Management
End-user
Payers
Providers
Billing & Payments
Administrative
Patient Education
In-patient Health
Management
Others
Others

23
Belgium PSP Market Share, By Functionality (2022)
Communication
Health Tracking
& Insights
Billing &
Payments
Administrative
Patient
Education
▪ Communication market in Belgium is a
significant component of the overall
PSP treatment market
▪ It has the maximum market share in
Belgium PSP market with
approximately xx%
final report
2.2.1 Market Segmentation: By Functionality
Illustrative

24
Belgium PSP Market Share, By Therapeutic Area (2022)
Health &
Wellness
Chronic Disease
Management
Others
2.2.2 Market Segmentation: By Therapeutic Area
▪ Health & wellness market in Belgium is
a significant component of the overall
PSP market
approximately xx%
final report
Illustrative

25
Belgium PSP Market Share, By Application (2022)
Population
Health
Management
Outpatient
Health
Management
In-patient Health
Management
Others
2.2.2 Market Segmentation: By Application
▪ Population health management market
in Belgium is a significant component of
the overall PSP market
approximately xx%
final report
Illustrative

26
Belgium PSP Market Share, By End User (2022)
Payers
Providers
Others
2.2.3 Market Segmentation: By End User
▪ Payers have the maximum market
share in Belgium PSP market with
approximately xx%
final report
Illustrative

3. Market Dynamics

28
3.1 Market growth drivers
▪ Number of people living with chronic diseases in Belgium is
increasing
▪ This is due to a number of factors, including the aging
population, the rising prevalence of obesity, and the increasing
environmental pollution
▪ As the number of people living with chronic diseases
increases, the demand for patient support programs is also
expected to increase
▪ Please be aware that this sample report is intended to provide
you with a brief overview of the kind of information and
analysis that will be presented in the final report
related to the topic or subject matter of interest
2010 2022 2030
3.1.1 Increasing prevalence of chronic diseases, prevalence of cardiovascular diseases was 30% and prevalence of
cancer was 25% in 2022
Increasing prevalence of chronic
diseases in Belgium
Illustrative

29
3.1 Market growth drivers (continued)
3.1.2 Increasing awareness for importance of patient engagement, government has initiated many healthcare
programs including, MyHealth@Home Program, Patient Empowerment Program and Patient Advocacy Network
▪ There is a growing recognition of the importance of patient
engagement in healthcare
▪ Patient engagement refers to the active participation of
patients in their own care
▪ Patient support programs can help to improve patient
engagement by providing patients with the information and
support they need to take an active role in their care
▪ Please be aware that this sample report is intended to
provide you with a brief overview of the kind of information
and analysis that will be presented in the final report
related to the topic or subject matter of interest 2010 2022 2030
Increasing government funding for PSPs
in Belgium
Illustrative

30
3.2 Market restraints
3.2.1 Data security and privacy
concerns, 75% of patients are
concerned about the security
of their health data
▪ Please be aware that this sample
report is intended to provide you
with a brief overview of the kind of
information and analysis that will
be presented in the final report
▪ In order to obtain access to all of
the information that you are
seeking, you will need to
purchase the final report
▪ Final report will be
comprehensive and detailed, and
it will include data, analysis,
trends, and other relevant
3.2.2 High cost of patient
support programs, the average
cost of a PSP in Belgium is
around $1,104 per participant
3.2.3 Lack of awareness, only
30% of patients are aware of
patient support programs in
Belgium
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative

4. Competitive Landscape

32
4.1 Major Market Share
XX
Other
▪ Belgium PSP market is a highly
competitive space, with many companies
developing and marketing PSP treatments
▪ Some of the top companies in Belgium
PSP market based on revenue and market
share include
report
interest
Revenue of Major players in Belgium PSP Market ($ Mn)
Illustrative

33
4.2 Key Company Profile
▪ Here is the list of top 10 companies which
will cover in the final report
▪ Each company will have slides for
o Overview
o Key details
o Offerings
o Name of products
o Recent activities/ Press Coverage
o Distribution and Vendor Partners
o Mergers, Acquisitions and
Collaboration
o Financials
▪ If there are specific companies that you
would like to be included in the report,
please let us know via email
1 IQVIA
3 Domo Health
5 Simmons & Simmons
7 Novellas healthcare
9 Healthentia
2 Inizio Engage
4 Comarch
6 Remedus
8 Ashfield Engage
Marti farm
10
Key Note:

34
4.2.1 IQVIA
Founded in: 1982
HQ: Durham, US
Type: Public
Revenue: $15.150 Bn
Website: www.iqvia
▪ IQVIA is a world leader in using data, technology, advanced
analytics and human expertise to help customers drive
healthcare - and human health – forward
▪ IQVIA has over 79,000 employees and operates in more than
100 countries
▪ Company's expertise, experience, and scalability make it a
valuable partner for pharmaceutical companies, biotechnology
companies, medical device companies, and government
agencies
Solutions offered by IQVIA
➢ Hospital solutions
➢ Business intelligence & data science
➢ Sales, medical & marketing services
➢ Commercial technologies
➢ Real world evidence
➢ Activation services
Financial assistance Education and Counselling Technology enabled engagement Clinical support and intervention
Co-pay management Home nurse visits Remote monitoring Drug administration
Claims support Inbound support line Patient apps Home based clinical support
Prior authorization Outbound calls/reminders Artificial intelligence Medical tests
Loan management SMS reminders
Numerous patient support programs offered

35
4.2.1 IQVIA (continued)
Major Vendor Partners
Partnerships Ecosystem
IQVIA and Athenahealth work together to provide patient support programs that are integrated with EHRs,
making it easier for patients to access the information and services they need
Cognizant is a global information technology company that provides a wide range of services to the
healthcare industry. IQVIA and Cognizant work together to provide patient support programs that are
designed to improve patient adherence and outcomes
Evolent Health is a healthcare technology company that provides a platform for healthcare providers to
collaborate and share data. IQVIA and Evolent Health work together to provide patient support programs
that are data-driven, making it easier for providers to track patient progress and identify areas for
improvement
HealthcareSource is a healthcare staffing company that provides a range of services to healthcare
providers, including patient support services

36
Company Name Type
Amount /
Duration
Year Key Pointers
Janssen
Partnership - January, 2023
▪ Partnership between IQVIA and Janssen will combine IQVIA's
patient support program expertise with Janssen's deep
understanding of its products
▪ This will allow the two companies to create patient support
programs that are tailored to the specific needs of Janssen's
patients
▪ Partnership will also leverage IQVIA's technology solutions to
provide Janssen with a more data-driven approach to patient
support
MedaCare
Acquisition $191 Mn March 2022
▪ MedaCare is a leading patient support services company in
Belgium
▪ Company provides a range of services to pharmaceutical
companies, including patient education, monitoring, and
adherence support
▪ IQVIA's acquisition of MedaCare will allow the company to
expand its patient support program capabilities in Belgium and
across Europe
Latest Deals - Mergers and Acquisitions

37
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
report
▪ In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
interest
Illustrative

38
4.2.2 Healthentia
Founded in:
HQ:
Type:
Revenue:
Website:
▪ In 2021, Healthentia medical device entered the market of
Patient Support Programs (PSP) as a decision support software
intended to monitor, detect and predict outcomes, offer virtual
coaching services and generate automatic alerts regarding
events, based on Real World Data gathered from patients
▪ Healthentia PSPs are offered jointly with healthcare
organizations and pharmaceutical companies and follow co-
development, participatory-design, and patient-centric
approaches
Solutions offered by Company
Drugs Indications
Drugs for PSP Recent Activity / Press Coverage
• In 2022 Healthentia is expected to collect evidence that will create
clinical claims on its efficacy as a therapeutic device.
Illustrative

39
4.2.2 Company 2 (continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem

40
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals - Mergers and Acquisitions

41
xx xx xx
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Revenues ($Bn), 2020-2030 ▪ Please be aware that this sample report is
report
▪ In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
interest
Breakdown of Net Revenue by Segment, 2022
1 2 3 4

5. Reimbursement Scenario

43
5.1 Reimbursement Regulation
The reimbursement scenario in the Belgium PSP market is complex and can vary
depending on the specific treatment, setting of care, and insurance coverage.
Here are some key points to consider:
▪ Public:
o Public is a federal health insurance program for people aged 65 and
older, as well as people with certain disabilities or health conditions
o Public covers many PSP treatments, including chemotherapy, radiation
therapy, and some immunotherapies
o However, coverage can be subject to strict guidelines and restrictions,
such as the requirement for prior authorization
▪ Private:
o Private is a joint federal-state program that provides health insurance
for people with low incomes
o Private coverage for PSP treatments can vary by state, and may be
subject to limits on the amount and type of treatment covered
▪ Private Insurance:
o Private insurance coverage for PSP treatments can also vary widely
depending on the insurer and the specific policy
o Some policies may have high out-of-pocket costs, such as deductibles
and co-pays, while others may have more comprehensive coverage
Public and Private together provide
health insurance coverage for more than
4 in 10 Belgians
Employer-Sponsored
47%
Private
16%
Public
23%
Uninsured
14%
Health Insurance Coverage, 2022
Illustrative

44
5.1 Reimbursement Regulation (continued)
▪ Affordable Care Act:
o Affordable Care Act (ACA) includes provisions to help improve access to PSP treatments by requiring insurers to cover
certain preventive services, including PSP screenings, without co-pays or deductibles
o It also includes protections for people with pre-existing conditions, such as PSP
▪ Reimbursement for New Treatments:
o Reimbursement for new PSP treatments can be a complex and lengthy process, as insurers and government programs often
require evidence of safety and effectiveness before providing coverage
o This can create challenges for companies developing and marketing new treatments
▪ Value-Based Care:
o There is a growing trend towards value-based care, which aims to improve outcomes and lower costs by focusing on the
value of treatments rather than simply the volume of treatments
o Value-based care models can include payment models that tie reimbursement to outcomes or performance metrics
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative

45
5.1 Reimbursement Regulation (continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
 Public healthcare coverage is provided by the government and includes programs like
Public and Private
 Public is a federal program that provides healthcare coverage to individuals who are
65 years of age or older, as well as certain younger people with disabilities
 Private is a joint federal-state program that provides healthcare coverage to
individuals with low income and limited resources
▪ Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care 38.9%
37.1%
35.6%
32.5%
31.5%
44.0%
46.0%
47.7%
51.0%
51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx xx xx xx xx
2012 2013 2014 2015 2016
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative

46
5.2 Reimbursement Process for Diagnosis
The reimbursement process in the US healthcare system can be complex and can vary depending on the type of healthcare service,
the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪ Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪ Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the
service provided
▪ Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for
reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential
errors or fraud
▪ Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service
provided, based on the negotiated payment rates or fee schedule
▪ Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost
of the service, such as deductibles, co-payments, or co-insurance
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative

47
5.3 Reimbursement Process for Treatment
The reimbursement process in the US healthcare system can be complex
and can vary depending on the type of healthcare service, the healthcare
provider, and the insurance coverage. Here are the general steps involved
in the reimbursement process:
▪ Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪ Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪ Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪ Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
FDA
Private Payers Public Payers
Health Technology Assessment
Payment
Coverage
Coding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 3
2
Illustrative

6. Methodology & Scope

Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

Analysis Methodology
Our Analysis Methodology involves three critical stages:
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Market Data Analysis
& Statistical Model
Interpretation &
Presentation
Secondary
Research
Proprietary
Database
Data
Collection
Primary
Research

Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

2022
2023-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (3 to 5 working days)
with purchase. We will provide you with data
that is currently not a part of our scope as a
part of customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
www.insights10.com
Lifesciences Market
Research Reports you
can trust

www.insights10.com
A large database of over 30,000 syndicated
market research reports in Healthcare Services
and healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Get actionable insights to
take informed business
decisions

Our qualitative, acute, and result-oriented market
research reports provide a comprehensive
understanding of the business scenario and the
latest trends related to the life sciences market
Elevate your business plans
with in-depth market analysis
and industry intelligence
www.insights10.com

Whether you are looking to expand into new
areas, develop new products, or take advantage
of new opportunities we have reports to help you
accelerate and improve your plans by identifying
unique growth prospects.
Gain a competitive edge with
Insights10's customized
healthcare research solutions
www.insights10.com

Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Healthcare Services
(Diseases & Drugs)
Digital
Health
Medical
Devices
across various categories
Market Research Reports

FEATURED REPORTS FREE SAMPLE REPORTS
TRENDING TOPICS

1200+
Reports
Published
Annually
30000+
Life science
Market Research
Reports
22000+
Country
Specific
Reports
2000+
Rare & orphan
Disease
Reports
What makes us different?

Market Overview
Growth Drivers &
Growth Restraints
Market Segmentation
Market Share Factors Driving Future Growth
Reimbursement Scenario
Policy & Regulatory
Landscape
Key Company Profiles
Epidemiology &
Disease type
Competitive Landscape
insights on
which our
reports are
based
1
2
3
4
5
6
10
9
8
7
Table of Contents

Subscription
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database
Service
Primary
Research
Customized
Reports
Market Research
Reports
Our Services

Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis

Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players

What kind of data is presented
in our reports?
Our reports present data, which is:
The report is
prepared using a
proven methodology
and insightful
research
Reliable
The data is prepared
by a team of highly
qualified &
experienced research
analysts & vetted by
our local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything
you would need to
know about the
market including
market size,
competitive analysis
& much more
Comprehensive
You do not have to
be a market expert
to understand what
really is happening
on the market and
how it works
Easy to read

“The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market.
We at Insights10 are building the future of market
research and are committed to providing our clients with
the right intelligence and insights to make business
decisions quickly and efficiently.
Insighs10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working
with some of the best organizations in the world,
generating insights that provides substantial competitive
advantage.”
Dr. Purav Gandhi
Founder & CEO

Purav is a physician and an entrepreneur
with 12+ years of experience in Healthcare
& Life Sciences industry spanning across
strategy, market access, health informatics
and RWE, digital health, analytics and data
science. Purav studied medicine from
Gujarat University and also completed his
MBA from IIM-Kozhikode. Purav started
his career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of experience
in management consulting in the
Life Sciences sector, and has
worked with diverse multinational
firms in the US, India, Middle East
and APAC regions. His primary
area of interest is Customer and
Market Strategy, Market Access,
and Digital Health with special
focus on emerging markets like
Africa, Middle East and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Leadership Team
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research & marketing
professional with a progressive
experience of over 20 years in Life
Sciences, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across diff.
markets (America, Europe, Africa, APAC
and Middle East). Her areas of expertise
include: Indentifying emerging trends in life
sciences industry, Competitor landscape
assessment, Disease opportunity
assessments etc. She is a pro in secondary
and primary research with a deep domain
expertise in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?

www.insights10.com
Thank you
We truly appreciate your business and
look forward to serving you.

Belgium Patient Support Programs (PSP) Market Analysis Sample Report

Belgium Patient Support Programs (PSP) Market Analysis Sample Report

Recommended

Recommended

More Related Content

Similar to Belgium Patient Support Programs (PSP) Market Analysis Sample Report

Similar to Belgium Patient Support Programs (PSP) Market Analysis Sample Report (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

Belgium Patient Support Programs (PSP) Market Analysis Sample Report